BT3.F - BioTime, Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
1.0920
+0.0260 (+2.44%)
As of 8:00AM CEST. Market open.
Stock chart is not supported by your current browser
Previous Close1.0660
Open1.0920
Bid1.0920 x 250000
Ask1.1350 x 250000
Day's Range1.0920 - 1.0920
52 Week Range0.7520 - 2.4800
Volume500
Avg. Volume1,701
Market Cap165.781M
Beta (3Y Monthly)2.61
PE Ratio (TTM)N/A
EPS (TTM)-0.3620
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Associated Presslast month

    BioTime: 4Q Earnings Snapshot

    The Alameda, California-based company said it had a loss of 35 cents per share. Losses, adjusted for non-recurring costs, came to 7 cents per share. The results met Wall Street expectations. The average ...

  • Associated Press5 months ago

    BioTime: 3Q Earnings Snapshot

    On a per-share basis, the Alameda, California-based company said it had net income of 53 cents. Losses, adjusted for non-recurring gains, were 7 cents per share. The biotechnology company posted revenue ...

  • Earnings Preview: BioTime (BTX) Q3 Earnings Expected to Decline
    Zacks6 months ago

    Earnings Preview: BioTime (BTX) Q3 Earnings Expected to Decline

    BioTime (BTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Can The Uptrend Continue for BioTime (BTX)?
    Zacks8 months ago

    Can The Uptrend Continue for BioTime (BTX)?

    Investors certainly have to be happy with BioTime, Inc. (BTX) and its short term performance.

  • BioTime (BTX) Reports Q2 Loss, Tops Revenue Estimates
    Zacks9 months ago

    BioTime (BTX) Reports Q2 Loss, Tops Revenue Estimates

    BioTime (BTX) delivered earnings and revenue surprises of 33.33% and 671.82%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press9 months ago

    BioTime: 2Q Earnings Snapshot

    The Alameda, California-based company said it had a loss of 3 cents per share. Losses, adjusted for non-recurring gains, were 6 cents per share. The biotechnology company posted revenue of $2.5 million ...

  • Here's Why BioTime, Inc Rose as Much as 14.3% Today
    Motley Fool9 months ago

    Here's Why BioTime, Inc Rose as Much as 14.3% Today

    The small-cap biopharma company issued a simple reminder to investors.

  • BioTime (BTX) in Focus: Stock Moves 7.3% Higher
    Zacks9 months ago

    BioTime (BTX) in Focus: Stock Moves 7.3% Higher

    BioTime (BTX) was a big mover last session, as the company saw its shares rise more than 7% on the day.

  • BioTime Inc (NYSEMKT:BTX): Earnings Expected To Remain Subdued
    Simply Wall St.11 months ago

    BioTime Inc (NYSEMKT:BTX): Earnings Expected To Remain Subdued

    In December 2017, BioTime Inc (AMEX:BTX) released its latest earnings announcement, which signalled tough times for the business, with earnings reversing into losses due to recent headwinds. Below is myRead More...